Vistagen Therapeutics, Inc.Vistagen Therapeutics, Inc.Vistagen Therapeutics, Inc.

Vistagen Therapeutics, Inc.

Inga transaktioner
Se i superdiagram

VTGN fundamenta

Vistagen Therapeutics, Inc. earnings per share and revenue

VTGN earnings per share for the last quarter are 0.30 USD whereas the estimation was -0.36 USD which accounts for 182.76% surprise. Företagets omsättning för samma period uppgår till 194.00 k USD trots den uppskattade siffran 405.70 k USD. Estimated earnings per share for the next quarter are -0.41 USD, and revenue is expected to reach 298.65 k USD. Also watch annual changes over time to get a bigger picture of VTGN earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
Utdelning per andel
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning
Omsättning
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning